Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET

Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer

NCT06914999 ·Status: RECRUITING ·Phase: EARLY_PHASE1

PET With [18F]HX4 in Head and Neck Cancer

NCT01347281 ·Status: COMPLETED ·Phase: NA

Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer

NCT00135161 ·Status: COMPLETED ·Phase: PHASE1

Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors

NCT00163176 ·Status: COMPLETED

Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer

NCT06171464 ·Status: COMPLETED

Measurement of Head and Neck Tumor Hypoxia With PET-MRI

NCT05246475 ·Status: RECRUITING ·Phase: NA

Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer

NCT03575949 ·Status: COMPLETED ·Phase: NA

PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy

NCT00809016 ·Status: COMPLETED ·Phase: NA

3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx

NCT00757549 ·Status: COMPLETED ·Phase: EARLY_PHASE1

The Diagnostic Value of PET/MRI in Head and Neck Cancer

NCT04117139 ·Status: UNKNOWN ·Phase: NA

18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC

NCT04196985 ·Status: UNKNOWN ·Phase: NA

PET/MR in Radiotherapy for Head and Neck Cancer Pilot

NCT02952625 ·Status: COMPLETED ·Phase: NA

Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer

NCT07285564 ·Status: RECRUITING ·Phase: NA

FDG-PET/CT in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed H&N Cancer

NCT00983697 ·Status: UNKNOWN ·Phase: NA

Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer

NCT02469922 ·Status: COMPLETED ·Phase: NA

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

NCT01827709 ·Status: TERMINATED ·Phase: NA

Prognostic Value of 18FDG PET/CT Textural Indices in HNSCC

NCT03378193 ·Status: COMPLETED

Whole-Body 18F-FDG PET in Induction Chemotherapeutic Response for Advanced NPC Patients

NCT00304694 ·Status: UNKNOWN

18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma

NCT04813705 ·Status: RECRUITING ·Phase: PHASE2

Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

NCT05889312 ·Status: RECRUITING

Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma

NCT02515084 ·Status: COMPLETED ·Phase: PHASE2

Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer

NCT00647140 ·Status: TERMINATED ·Phase: PHASE2

A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation

NCT00847509 ·Status: COMPLETED ·Phase: NA

The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers

NCT00230269 ·Status: COMPLETED

Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma

NCT03636945 ·Status: UNKNOWN ·Phase: NA